Trade Krystal Biotech, Inc. - KRYS CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.53 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023346% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.001124% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 0.1 | ||||||||
| Currency | USD | ||||||||
| Margin | 50.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 168.84 |
| Open | 163.9 |
| 1-Year Change | 3.14% |
| Day's Range | 163.9 - 169.08 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Apr 25, 2025 | 167.59 | 1.52 | 0.92% | 166.07 | 169.08 | 162.67 |
| Apr 24, 2025 | 168.84 | 3.13 | 1.89% | 165.71 | 169.13 | 162.82 |
| Apr 23, 2025 | 165.50 | -6.45 | -3.75% | 171.95 | 174.90 | 165.50 |
| Apr 22, 2025 | 168.55 | 7.49 | 4.65% | 161.06 | 169.19 | 161.06 |
| Apr 21, 2025 | 161.37 | -3.87 | -2.34% | 165.24 | 170.28 | 160.97 |
| Apr 17, 2025 | 168.30 | 7.35 | 4.57% | 160.95 | 168.62 | 159.97 |
| Apr 16, 2025 | 164.35 | 3.76 | 2.34% | 160.59 | 166.80 | 160.59 |
| Apr 15, 2025 | 168.90 | 3.16 | 1.91% | 165.74 | 170.16 | 165.13 |
| Apr 14, 2025 | 168.43 | 2.06 | 1.24% | 166.37 | 169.65 | 159.56 |
| Apr 11, 2025 | 164.51 | 8.17 | 5.23% | 156.34 | 166.75 | 154.06 |
| Apr 10, 2025 | 160.51 | -1.44 | -0.89% | 161.95 | 166.92 | 154.08 |
| Apr 9, 2025 | 167.94 | 15.39 | 10.09% | 152.55 | 168.31 | 149.95 |
| Apr 8, 2025 | 158.38 | -9.57 | -5.70% | 167.95 | 172.26 | 155.80 |
| Apr 7, 2025 | 165.86 | 0.91 | 0.55% | 164.95 | 174.95 | 158.80 |
| Apr 4, 2025 | 170.90 | 1.45 | 0.86% | 169.45 | 173.49 | 166.45 |
| Apr 3, 2025 | 177.41 | 3.71 | 2.14% | 173.70 | 179.22 | 169.72 |
| Apr 2, 2025 | 180.80 | 7.10 | 4.09% | 173.70 | 181.82 | 173.65 |
| Apr 1, 2025 | 174.37 | -3.70 | -2.08% | 178.07 | 180.99 | 173.62 |
| Mar 31, 2025 | 179.93 | -0.06 | -0.03% | 179.99 | 181.51 | 175.42 |
| Mar 28, 2025 | 183.45 | 1.50 | 0.82% | 181.95 | 185.08 | 180.65 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 20
- 100
- 500
- 1000
- 10000
Krystal Biotech, Inc. Company profile
About Krystal Biotech Inc
Krystal Biotech, Inc. is a clinical stage biotechnology company focused on redosable gene delivery for the treatment of serious rare diseases. Using its platform that is based on engineered herpes simplex virus type 1 (HSV-1), the Company create vectors that deliver therapeutic transgenes to cells of interest in multiple organ systems. The Company’s gene therapy product candidates and undertaking preclinical studies and clinical trials of B-VEC, KB105, KB301, KB104, KB407 and KB408. The Company's KB104 is to treat Netherton Syndrome, a severe form of ichthyosis, which is a family of genetic skin disorders associated with thickened scaly skin and characterized by chronic skin inflammation, itchiness, and dehydration.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, Krystal Biotech Inc revenues was not reported. Net loss increased from $32.2M to $69.6M. Higher net loss reflects General and Administrative - Balancing increase from $12.8M to $30.2M (expense), Stock-based Compensation in SGA increase from $2.3M to $10.2M (expense), Research and Development - Balancing increase of 44% to $24.5M (expense).
| Industry: | Bio Therapeutic Drugs |
2100 Wharton St Ste 701
PITTSBURGH
PENNSYLVANIA 15203
US
News
ECB interest-rate forecasts – Projections for the next five years
The European Central Bank (ECB) plays a pivotal role in the economic stability of the eurozone, meaning ECB interest-rate forecasts are key to understanding how financial and economic scenarios might evolve.
14:37, 10 April 2025
BlackRock shareholders: Who owns the most BLK stock?
BlackRock is the leading asset manager in the world – but who are its biggest shareholders? Read on to find out.
13:46, 9 April 2025
Bitcoin price predictions 2025–2050: third-party price target
We examine bitcoin price predictions for 2025 and beyond, with insights from third-party analysts and market experts.
10:28, 9 April 2025
Tesla (TSLA) stock forecast 2025 and beyond: third-party Tesla price target
Where will Tesla’s stock be in five years? Can the EV company keep its crown?
08:19, 9 April 2025
JasmyCoin price predictions 2025-2030: Third-party price target
How might JASMY behave in the future?
16:13, 8 April 2025
Australian interest-rate projections: where will rates be in 5 years?
As one of the most closely watched economic indicators, Australian interest-rate projections offer valuable insight into the future of the country’s economy.
21:37, 7 April 2025
Copper price forecast: third-party price target
What’s next for the copper market? Read on for the latest analysis of the commodity's price and potential outlook.
17:31, 14 March 2025People also watch
Still looking for a broker you can trust?
Join the 720,000+ traders worldwide that chose to trade with Capital.com